Study of the Week: Nearly a Fifth of Sickle Cell Disease Patients May Develop Craniosynostosis
source: pixabay.com

Study of the Week: Nearly a Fifth of Sickle Cell Disease Patients May Develop Craniosynostosis

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Nearly a Fifth of Sickle Cell Disease Patients May Develop Craniosynostosis

Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent

Medscape Medical News reports that results have been received from the OCCLURANDOM Phase 2 trial which is the first randomized trial investigating the antitumor effect of the peptide receptor radionuclide…

Continue Reading Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent